Log in

OTCMKTS:CLIGF - Clinigen Group Stock Price, Forecast & News

$12.30
0.00 (0.00 %)
(As of 01/15/2020)
Today's Range
$12.30
Now: $12.30
$12.30
50-Day Range
$10.05
MA: $11.60
$12.30
52-Week Range
$10.17
Now: $12.30
$10.70
Volume1,872 shs
Average Volume94 shs
Market Capitalization$1.51 billion
P/E Ratio17.83
Dividend YieldN/A
Beta-0.33

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CLIGF
Previous SymbolNASDAQ:CLIGF
CUSIPN/A
CIKN/A
Phone44-12-8349-5010

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$591.34 million
Cash Flow$1.19 per share
Book Value$4.68 per share

Profitability

Miscellaneous

Employees1,133
Market Cap$1.51 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive CLIGF News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIGF and its competitors with MarketBeat's FREE daily newsletter.


Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."

Has Clinigen Group been receiving favorable news coverage?

News headlines about CLIGF stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Clinigen Group earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Clinigen Group.

Who are some of Clinigen Group's key competitors?

What other stocks do shareholders of Clinigen Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Agile Therapeutics (AGRX), Frequency Therapeutics (FREQ), Foamix Pharmaceuticals (FOMX), Fulcrum Therapeutics (FULC), Provention Bio (PRVB), Soligenix (SNGX), Xilinx (XLNX), Dillard's (DDS), Encompass Health (EHC) and Kion Group (KGX).

How do I buy shares of Clinigen Group?

Shares of CLIGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Clinigen Group's stock price today?

One share of CLIGF stock can currently be purchased for approximately $12.30.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of $1.51 billion and generates $591.34 million in revenue each year. The company earns $6.78 million in net income (profit) each year or $0.69 on an earnings per share basis. Clinigen Group employs 1,133 workers across the globe.View Additional Information About Clinigen Group.

What is Clinigen Group's official website?

The official website for Clinigen Group is http://www.clinigengroup.com/.

How can I contact Clinigen Group?

Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, Burton-on-Trent X0, DE14 2WW. The company can be reached via phone at 44-12-8349-5010.


MarketBeat Community Rating for Clinigen Group (OTCMKTS CLIGF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  110 (Vote Underperform)
Total Votes:  189
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIGF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIGF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: What are economic reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel